Page last updated: 2024-08-21

pyrazines and Lipodystrophy

pyrazines has been researched along with Lipodystrophy in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Konishi, H; Kyohara, M; Okuyama, T; Shirakawa, J; Tajima, K; Terauchi, Y; Togashi, Y; Yamazaki, S1
Cicalini, S; D'Abbraccio, M; d'Ettorre, G; Di Biagio, A; Maggi, P; Martinelli, C; Nunnari, G; Rusconi, S; Sighinolfi, L; Spagnuolo, V; Squillace, N1
Ditlevsen, S; Lindegaard, B; Mittendorfer, B; Pedersen, BK; Plomgaard, P1
Aliabadi, N; Breu, J; Grinspoon, S; Hadigan, C; Meininger, G; Rabe, J1

Reviews

1 review(s) available for pyrazines and Lipodystrophy

ArticleYear
Cardiovascular risk and dyslipidemia among persons living with HIV: a review.
    BMC infectious diseases, 2017, 08-09, Volume: 17, Issue:1

    Topics: Anti-HIV Agents; Cardiovascular Diseases; Cholesterol; Dyslipidemias; Growth Hormone-Releasing Hormone; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lipodystrophy; Pyrazines; Risk Factors

2017

Trials

2 trial(s) available for pyrazines and Lipodystrophy

ArticleYear
Acute reduction of lipolysis reduces adiponectin and IL-18: evidence from an intervention study with acipimox and insulin.
    Diabetologia, 2013, Volume: 56, Issue:9

    Topics: Adiponectin; Cross-Over Studies; Female; Humans; Insulin; Interleukin-18; Lipodystrophy; Lipolysis; Male; Middle Aged; Pyrazines

2013
Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution.
    The American journal of clinical nutrition, 2003, Volume: 77, Issue:2

    Topics: Adipose Tissue; Adult; Area Under Curve; Fasting; Fatty Acids; Glucose Tolerance Test; HIV Infections; Humans; Hyperinsulinism; Hypolipidemic Agents; Insulin Resistance; Lipodystrophy; Lipolysis; Male; Middle Aged; Protease Inhibitors; Pyrazines; Viscera

2003

Other Studies

1 other study(ies) available for pyrazines and Lipodystrophy

ArticleYear
Metabolic recovery of lipodystrophy, liver steatosis, and pancreatic β cell proliferation after the withdrawal of OSI-906.
    Scientific reports, 2017, 06-23, Volume: 7, Issue:1

    Topics: Animals; Cell Proliferation; Dietary Supplements; Energy Metabolism; Fatty Liver; Hyperglycemia; Hyperinsulinism; Hyperlipidemias; Imidazoles; Insulin-Secreting Cells; Leptin; Lipodystrophy; Mice; Pyrazines; Safety-Based Drug Withdrawals; Time Factors; Tomography, X-Ray Computed

2017